Efficacy and safety of topical JTE‐052, a Janus kinase inhibitor, in Japanese adult patients with moderate‐to‐severe atopic dermatitis: a phase II, multicentre, randomized, vehicle‐controlled clinical study
H. Nakagawa; O. Nemoto; A. Igarashi; T. Nagata
Author Information: Department of Dermatology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.